Although ZFP strongly correlated with liver disease severity and emerged as the best indicator of outcome in our cohort, its close association with serum albumin levels and inverse correlation with the MELD score and its components restrict its utility as a biomarker for IP or ‘leaky gut’ in advanced liver disease. The gene discussed is ALB; the disease is liver disorder.